Increase/Decrease in Cash: The total change in cash for the company over the given period.
LENZ Therapeutics, Inc. (LENZ) had Increase/Decrease in Cash of $6.02M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-10.21M |
|
-- |
|
-- |
|
$12.95M |
|
$-12.95M |
|
$2.73M |
|
$-10.21M |
|
$-10.21M |
|
$-10.21M |
|
$-10.21M |
|
$-10.21M |
|
$-10.21M |
|
$-12.95M |
|
$-14.29M |
|
27.17M |
|
27.17M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$220.70M |
|
$0.37M |
|
$3.30M |
|
$224.01M |
|
$7.71M |
|
-- |
|
$1.02M |
|
$8.73M |
|
$215.28M |
|
$215.28M |
|
$215.28M |
|
27.48M |
|
| Cash Flow Statement Financials | |
$-50.31M |
|
$-142.62M |
|
$198.95M |
|
$35.14M |
|
$41.16M |
|
|
Increase/Decrease in Cash |
$6.02M |
$4.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-50.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.75% |
|
-4.75% |
|
-4.56% |
|
-4.75% |
|
$7.83 |
|
$-1.86 |
|
$-1.85 |
|